Directorio

We are doing this study to collect information about how well dabrafenib plus trametinib works in patients who have unresectable (cannot be removed by surgery) or metastatic BRAF V600E mutation positive solid tumors.

We are doing this study to find out if the combination of the drugs Dapansutrile and Pembrolizumab is a safe and effective treatment for people with melanoma that does not improve after PD-1 therapy.

We are doing this study to collect and store information and samples that will be used for future research studies about transplants.

We are doing this study to collect and store your medical information and specimens for use in future research studies to understand heart function and disease.

We are doing this study to learn more about the DELFI Lung Cancer Screening Test. We want to know when it is most appropriate and beneficial for people to have this test. The test is designed to diagnose lung cancer early through blood analysis.

If you choose to join this study, you will complete up to 10 study visits and 2 phone call check-ins over 72 weeks. This study includes:<ul>
<li>Pulmonary function tests (how well your lungs are working)</li>
<li>CT scans of the chest (a special type of imaging that creates 3D X-ray images)</li>
<li>Blood draws</li>
<li>Questionnaires</li></ul>
During the study, you will be randomized (like flipping a coin) to get either:
<li>The study drug (Doxycycline) by mouth twice a day for 72 weeks; OR</li>
<li>A placebo (sugar pill) by mouth twice a day for 72 weeks</li></ul>

We are building a database of people who would like to be contacted about future dermatology research studies. This is a way for people who are interested in participating in research opportunities to learn about a research study that they may not have otherwise known about.

We are doing this study to understand if lowering the radiation dose will work in maintaining high rates of disease control and lessen the short term and long term treatment side effects.